TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
2 hedge funds and large institutions have $124K invested in TITAN PHARMACEUTICAL INC in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
19% less capital invested
Capital invested by funds: $153K → $124K (-$29K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$3.24K |
TTP Hedge Fund Activity: Q1 2017 in Review
2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q1 2017, worth a combined $124K — down 19% from $153K a quarter earlier.
Fund positioning in TTP was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Gagnon Securities, cutting an estimated $3.24K.
- 2 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $124K of TITAN PHARMACEUTICAL INC stock for Q1 2017, down 19% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q1 2017 and 0 closed out.
- The largest TITAN PHARMACEUTICAL INC seller in Q1 2017 was Gagnon Securities, an estimated $3.24K sold.
Based on aggregated 13F filings for Q1 2017.